Removal of hepatitis C virus-infected cells by a zymogenized bacterial toxin.
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease and has become a global health threat. No HCV vaccine is currently available and treatment with antiviral therapy is associated with adverse side effects. Moreover, there is no preventive therapy for recurrent hepatitis C po...
Main Authors: | Assaf Shapira, Shiran Shapira, Meital Gal-Tanamy, Romy Zemel, Ran Tur-Kaspa, Itai Benhar |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22359682/pdf/?tool=EBI |
Similar Items
-
Engineered toxins "zymoxins" are activated by the HCV NS3 protease by removal of an inhibitory protein domain.
by: Assaf Shapira, et al.
Published: (2011-01-01) -
Toxin-Based Therapeutic Approaches
by: Itai Benhar, et al.
Published: (2010-10-01) -
25-Hydroxyvitamin D Inhibits Hepatitis C Virus Production in Hepatocellular Carcinoma Cell Line by a Vitamin D Receptor-Independent Mechanism
by: Amiram Ravid, et al.
Published: (2019-05-01) -
Tracking Down the Epigenetic Footprint of HCV-Induced Hepatocarcinogenesis
by: Tom Domovitz, et al.
Published: (2021-02-01) -
Circular zymogens of human ribonuclease 1
by: Windsor, Ian W., et al.
Published: (2022)